Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
Drive Gaussia luciferase expression as a reporter for gene regulation studies using vectors with a multiple cloning site (MCS) or control promoter (CMV or TK).
Drive red-shifted firefly luciferase expression as a reporter for gene regulation studies using vectors with a multiple cloning site (MCS) or control promoter (CMV or TK).
Drive Cypridina luciferase expression as a reporter for gene regulation studies using vectors with a multiple cloning site (MCS) or control promoter (CMV or TK).
The Nano-Glo™ Luciferase Assay System provides a simple, single-addition reagent that generates a glow-type signal in the presence of NanoLuc luciferase with a half-life of approximately 120 minutes in commonly used tissue culture media.
The Nano-Glo™ Dual-Luciferase Reporter (NanoDLR) Assay System is a homogeneous reagent system that allows you to sequentially detect the activities of firefly (Photinus pyralis) luciferase and NanoLuc luciferase (Nluc) from a single sample.
The Bio-Glo™ Luciferase Assay System provides a highly sensitive, robust, homogeneous reagent, the Bio-Glo™ Assay reagent with a new luciferase substrate, for the detection of firefly luciferase reporter gene expression in the ADCC Reporter Bioassay.
ONE-Glo™ EX Luciferase Assay System provides both the high sensitivity and long-lived luminescence required to batch-process multiple 96-, 384- or 1,536-well plates. The approximately 2-hour signal half-life provides greater flexibility in assay design.
The Nano-Glo In-Gel Detection System directly detects the luminescence of NanoLuc fusion proteins in polyacrylamide gels after protein separation by PAGE under native or denaturing SDS conditions (native PAGE or SDS-PAGE).
Generate N-Terminal fusions to NanoLuc™ Luciferase Reporter. The pFN31A and pFN31K Nluc CMV-neo Flexi™ Vectors use a directional cloning method based on two rare-cutting restriction enzymes, SgfI and PmeI, and contain a mammalian selectable marker to create a stable line.